Also, the median ratio of two pneumococcal strains in a given sample was balanced (median 1.3).
Patients will be selected through purposive sampling to include all types of treatment (surgery, radiotherapy, hormone therapy, watchful waiting), cancer stage (localised, locally advanced/advanced), and represent a balanced median split for age and level of need.
Intraoperatively patients with complications were more likely to receive a liberal fluid intervention regime (median 5.4 litres; range 2.5-12.3 litres vs. 5.0 litres; range 1.0-10.6 litres; p = 0.047), and were in a more positive fluid balance (median 4.7 litres; range 1.6-12.0 litres vs. 4.1 litres; range 0.2-9.4 0.2-9.4 p = 0.044) compared to patients without complitresons.
For Baby Boomers carrying a balance, the median balance is about $3,000.
Baseline characteristics were balanced between arms; median age was 66.0 y, 84.8% of pts were male, 86.3% had BCLC stage C disease, 16.7% were from Asia, 32.8% had macrovascular invasion, and 74.0% had extrahepatic disease.
Study characteristics of trials using surrogate outcomes and those using patient relevant outcomes were well balanced, except for median sample size (371 v 741) and single centre status (23% v 9%).
Baseline demographics of these patients have been described elsewhere and were well balanced between groups: median age was 63 years and 69% of patients had colon rather than rectal cancer in both groups (Amado et al, 2008).
As in Table 1, both cohorts were well balanced for age (median age 57 for TBI vs. 56 for no-TBI cohorts, p=0.13), sex (male 74 vs. 67%, p=0.05), donor sex (61 vs. 66%, p=0.16), time from diagnosis to transplant (median 51vs.4747 months, p=0.31).
However, this surveillance interval is balanced by a shorter median time to relapse for Old World temperate strains relative to all New World strains.
In the pre-docetaxel, abiraterone acetate phase III trial, the two arms were well balanced in terms of median age, time from diagnosis, baseline PSA, testosterone, levels of alkaline phosphatase, hemoglobin and lactate dehydrogenase (LDH), and the extent of bone and visceral disease as well as baseline pain [ 52].
The demographic and clinical characteristics of the treatment groups were well balanced at baseline and the median duration of treatment exposure was 907 days, excluding interruptions; the median follow-up was 1,022 days (2.8 years).
